Introduction A decreasing trend in pulmonary embolism (PE)-related mortality has been observed over the past two decades. 1 One of the drivers of the lower number of PE-related deaths across the European Union is advanced risk stratification that has been gradually introduced: right ventricle (RV) function and cardiac biomarkers, shown to be prognostic markers in acute PE, were incorporated into the European Society of Cardiology (ESC) and European Respiratory Society (ERS) risk stratification algorithm. 2 3 4 5 6 7 8 In short, patients are classified into a low, intermediate, or high-risk category.
← all excerpts
National Early Warning Score for Predicting Clinical Outcome of Acute Pulmonary Embolism in Intermediate-High Risk Patients.
1
—
—